157 related articles for article (PubMed ID: 26878828)
1. Safety, tolerability, and outcomes of regular automated red cell exchange transfusion in the management of sickle cell disease.
Tsitsikas DA; Sirigireddy B; Nzouakou R; Calvey A; Quinn J; Collins J; Orebayo F; Lewis N; Todd S; Amos RJ
J Clin Apher; 2016 Dec; 31(6):545-550. PubMed ID: 26878828
[TBL] [Abstract][Full Text] [Related]
2. A 5-year cost analysis of automated red cell exchange transfusion for the management of recurrent painful crises in adult patients with sickle cell disease.
Tsitsikas DA; Ekong A; Berg L; Hartzenberg J; Sirigireddy B; Lewis N; Solanki B; Amos RJ
Transfus Apher Sci; 2017 Jun; 56(3):466-469. PubMed ID: 28602485
[TBL] [Abstract][Full Text] [Related]
3. Partial Red Blood Cell Exchange in Children and Young Patients with Sickle Cell Disease: Manual Versus Automated Procedure.
Escobar C; Moniz M; Nunes P; Abadesso C; Ferreira T; Barra A; Lichtner A; Loureiro H; Dias A; Almeida H
Acta Med Port; 2017 Oct; 30(10):727-733. PubMed ID: 29268067
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
5. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload.
Dedeken L; Lê PQ; Rozen L; El Kenz H; Huybrechts S; Devalck C; Diallo S; Heijmans C; Ferster A
Transfusion; 2018 Jun; 58(6):1356-1362. PubMed ID: 29574950
[TBL] [Abstract][Full Text] [Related]
6. The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.
Kalff A; Dowsing C; Grigg A
Br J Haematol; 2010 Jun; 149(5):768-74. PubMed ID: 20346014
[TBL] [Abstract][Full Text] [Related]
7. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
8. Transfusion support for haemoglobinopathies.
Greenwalt TJ; Zelenski KR
Clin Haematol; 1984 Feb; 13(1):151-65. PubMed ID: 6373080
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
11. Automated red cell exchange procedures in patients with sickle cell disease.
Kozanoglu I; Boga C; Ozdogu H; Sezgin N; Kizilkilic E; Kural M
Transfus Apher Sci; 2007 Jun; 36(3):305-12. PubMed ID: 17584530
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
Hilliard LM; Williams BF; Lounsbury AE; Howard TH
Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
[TBL] [Abstract][Full Text] [Related]
13. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
[TBL] [Abstract][Full Text] [Related]
14. Transfusion therapy for sickle cell disease: a balancing act.
Chou ST
Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.
Poullin P; Sanderson F; Bernit E; Brun M; Berdah Y; Badens C
J Clin Apher; 2016 Oct; 31(5):429-33. PubMed ID: 26274351
[TBL] [Abstract][Full Text] [Related]
16. Use of red blood cell exchange for treating acute complications of sickle cell disease.
Kozanoglu I; Ozdogu H
Transfus Apher Sci; 2018 Feb; 57(1):23-26. PubMed ID: 29525569
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
[TBL] [Abstract][Full Text] [Related]
18. Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.
Mian HS; Ward R; Telfer P; Kaya B; Kuo KH
Hemoglobin; 2015; 39(5):310-5. PubMed ID: 26114740
[TBL] [Abstract][Full Text] [Related]
19. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
Chou ST; Fasano RM
Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
[TBL] [Abstract][Full Text] [Related]
20. [Transfusion and sickle cell disease: axes of transfusion safety optimization].
Noizat-Pirenne F
Transfus Clin Biol; 2014 May; 21(2):77-84. PubMed ID: 24811565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
